Cumberland Pharmaceuticals (CPIX) Long-Term Deferred Tax (2010 - 2020)

Cumberland Pharmaceuticals (CPIX) has 11 years of Long-Term Deferred Tax data on file, last reported at $21802.0 in Q3 2020.

• For the quarter ending Q3 2020, Long-Term Deferred Tax fell 50.0% year-over-year to $21802.0; the trailing twelve-month figure through Sep 2020 stood at $21802.0 (down 50.0% YoY), and the FY2019 full-year result was $21802.0, down 75.0% from the prior year.
• Long-Term Deferred Tax was little changed at $21802.0 in Q3 2020, from $21802.0 in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $3.5 million in Q1 2017 to a low of $21802.0 in Q4 2019.
• A 5-year average of $524076.1 and a median of $65407.5 in 2017 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax slumped 97.2% in 2017 and changed 0.0% in 2018, its largest moves.
• Tracing CPIX's Long-Term Deferred Tax over 5 years: stood at $3.1 million in 2016, then tumbled by 97.2% to $87210.0 in 2017, then changed by 0.0% to $87210.0 in 2018, then plunged by 75.0% to $21802.0 in 2019, then changed by 0.0% to $21802.0 in 2020.
• Business Quant data shows CPIX's Long-Term Deferred Tax at $21802.0 in Q3 2020, $21802.0 in Q2 2020, and $21802.0 in Q1 2020.